O'Shaughnessy Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.1K	Buy	319 +281	+739%	+$29.7K	﹤0.01%	2290
2025 Q4	$3.97K	Buy	+38	New	+$3.82K	﹤0.01%	2500
2021 Q4	–	Sell	-909	Closed	-$70K	–	2144
2021 Q3	$70K	Hold	909	–	–	﹤0.01%	1520
2021 Q2	$73K	Hold	909	–	–	﹤0.01%	1435
2021 Q1	$72K	Buy	+909	New	+$70.9K	﹤0.01%	1304

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

O'Shaughnessy Asset Management's PJP Position: Q1 2026 in Review

O'Shaughnessy Asset Management increased its Invesco Pharmaceuticals ETF (PJP) stake by 739% in Q1 2026, buying an estimated $29.7K and bringing the position to 319 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

O'Shaughnessy Asset Management first reported a position in PJP in Q1 2021 and has held it in 5 quarters since. The position peaked at $73K in Q2 2021. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

O'Shaughnessy Asset Management held 319 shares of Invesco Pharmaceuticals ETF worth $33.1K as of Q1 2026.
O'Shaughnessy Asset Management bought 281 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $29.7K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #2290 holding.
O'Shaughnessy Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2021 and has held it in 5 quarters since.
O'Shaughnessy Asset Management's Invesco Pharmaceuticals ETF position peaked at $73K in Q2 2021.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.